Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than R-GemOx
Sun Pharma gets 8 observations from USFDA for Halol facility
Dilip Shanghvi to continue as the Executive Chairman of the Board
25 women students to receive internship, training, and mentorship in Life Sciences segment
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Subscribe To Our Newsletter & Stay Updated
